OptimizeRx Corp — Director's Dealing 2023

Oct 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-10-11

Reporting Person: Stelmakh Edward (CFO/COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-11	Common Stock	M	8221	—	Acquired	25448	Direct
2023-10-11	Common Stock	M	6155	—	Acquired	31603	Direct
2023-10-11	Common Stock	F	2066	$7.15	Disposed	29537	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-11	Restricted Stock Units	$	M	8221	Disposed		Common Stock (8221)	Direct
2023-10-11	Restricted Stock Units	$	M	8221	Disposed		Common Stock (8221)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

F3: The restricted stock units vest in three equal annual installments beginning October 10, 2022, the first anniversary of the grant date.